Results 131 to 140 of about 13,000,271 (286)
Alternative Immunosuppression in Acquired Haemophilia A
Haemophilia, EarlyView.
Jayna Mistry+3 more
wiley +1 more source
Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis
ABSTRACT Background Emicizumab is a bispecific monoclonal antibody mimicking factor (F) VIII activity and an effective therapy for prophylaxis in people with haemophilia A (PWHA). The FVIII‐equivalent activity (FVIIIeq) of emicizumab remains unknown. Objectives To estimate FVIIIeq of emicizumab using global assays of haemostasis.
Daniel Kraemmer+6 more
wiley +1 more source
Splice junction mutations in factor IX gene resulting in severe hemophilia B [PDF]
S.H. Chen+4 more
openalex +1 more source
Radiological Stage of Hemophilic Arthropathy of Knee Does Not Correlate With Clinical Variables
ABSTRACT Background Various functional and radiological systems have been developed to evaluate joint health and the severity of arthropathy in hemophilic patients. Clinical relevance of these radiological systems has received minimal attention. Methods Through a retrospective chart review, 84 patients with end‐stage hemophilic arthropathy of the knee ...
Arman Vahabi+4 more
wiley +1 more source
Clinical audit of inherited bleeding disorders in a developing country
Objective: We did a clinical audit to determine the status of coagulation disorders in a hemophilia care center in Pakistan. Setting: Fatimid foundation blood bank and hematological diseases center, Lahore.
Sajid Raihan+4 more
doaj
Spinal Stenosis: An Emerging Complication of Ageing in People With Haemophilia
ABSTRACT Introduction Advances in haemophilia care have brought the challenges of ageing for people with haemophilia (PWH) to the forefront. Age‐related spinal degeneration may result in spinal stenosis; however, the rates in PWH are unknown. We sought to systematically review Irish PWH to address this gap in the current literature.
Claire Kelly+19 more
wiley +1 more source
Abstract Background Following the approval of the first gene therapies for haemophilia, it is essential to develop an optimal infrastructure for the administration of gene therapy. This can be ensured by identifying the criteria for the definition of treatment centres (hub centres) and follow‐up centres (spoke centres), as well as establishing ...
Wolfgang Miesbach+8 more
wiley +1 more source
Nephrotic Syndrome as a Complication of Immune Tolerance in Hemophilia B [PDF]
Bruce M. Ewenstein+7 more
openalex +1 more source
The Roles and Clinical Significance of Major Hepatic‐Derived Metabolites in Hepatocellular Carcinoma
ABSTRACT Hepatocellular carcinoma (HCC) is increasingly recognized as a metabolically orchestrated malignancy, in which hepatic‐derived metabolites function not only as byproducts of liver physiology but also as active modulators of tumor biology.
Rui Sun+5 more
wiley +1 more source
Hemophilia B Gene Therapy with a High‐Specific‐Activity Factor IX Variant
Lindsey A. George+27 more
semanticscholar +1 more source